Feb 15, 2022 05:49 PM (GMT+8) · EqualOcean
Tiantan Biological announcement, "intravenous covid-19 human immunoglobulin (pH4)" has completed the preparation work such as clinical ethics review, clinical medication customs clearance and pre clinical enrollment according to the requirements of drug clinical trial, and recently carried out the phase II clinical trial in the UAE.